The latest announcement is out from Agilon Health ( (AGL) ).
On May 6, 2025, Agilon Health reported its financial results for the first quarter ending March 31, 2025, with total revenues of $1.53 billion, a 4% decrease from the previous year. The company experienced a decrease in total members on its platform to 605,000, reflecting market exits, but maintained its strategic growth priorities through investments in technology and clinical programs to enhance value for stakeholders.
Spark’s Take on AGL Stock
According to Spark, TipRanks’ AI Analyst, AGL is a Neutral.
Agilon Health’s strong revenue and membership growth are overshadowed by persistent profitability challenges and negative cash flows. The technical indicators suggest limited momentum, while valuation metrics highlight the company’s struggle to generate earnings. Strategic plans discussed in the earnings call show potential, but the projected membership decline and cost management issues weigh on the overall score.
To see Spark’s full report on AGL stock, click here.
More about Agilon Health
Agilon Health operates in the healthcare industry, focusing on empowering physicians to transform healthcare in communities. The company provides services through its Total Care Model, aiming to deliver quality outcomes and cost-effective care, primarily to senior patients. Agilon Health’s market focus includes Medicare Advantage and ACO REACH model beneficiaries.
Average Trading Volume: 6,160,863
Technical Sentiment Signal: Hold
Current Market Cap: $1.72B
See more data about AGL stock on TipRanks’ Stock Analysis page.